Related Experiment Video
Updated: Jun 16, 2026

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube
Published on: April 28, 2020
Clinical and Laboratory Indicators Associated with Cirrhosis Severity
Fever and spontaneous bacterial peritonitis indicate advanced cirrhosis. Key lab markers like C-reactive protein (CRP), platelet count (PLT), and total bile acids (TBA) help assess cirrhosis severity and guide patient management.
Area of Science:
- Hepatology
- Clinical Medicine
- Biochemistry
Background:
- Cirrhosis severity assessment is crucial for patient management.
- Existing clinical and laboratory indicators require further evaluation for accuracy.
Purpose of the Study:
- To identify clinical and laboratory indicators associated with varying cirrhosis severity.
- To support more accurate clinical assessment and stratification of cirrhosis patients.
Main Methods:
- Retrospective analysis of 180 cirrhosis patients (Child-Pugh A, B, C).
- Stratification based on Child-Pugh classification.
- Statistical analysis to identify associations between variables and cirrhosis severity.
Main Results:
- Fever and spontaneous bacterial peritonitis were more frequent in advanced cirrhosis.
- Significant associations found between cirrhosis severity and serum calcium (Ca²⁺), white blood cell count (WBC), platelet count (PLT), C-reactive protein (CRP), hemoglobin (Hb), fibrinogen (FIB), total bile acids (TBA), apolipoprotein A1 (APOA1), direct bilirubin (DBIL), cholinesterase (CHE), cystatin C (CYSC), and bicarbonate (HCO3-).
- TBA and DBIL positively correlated with severity; FIB, APOA1, CHE, HCO3- negatively correlated.
Conclusions:
- Fever, spontaneous bacterial peritonitis, CRP, PLT, FIB, TBA, Ca²⁺, APOA1, CHE, CYSC, and HCO3- are relevant indicators for cirrhosis severity.
- These indicators can aid in improved clinical stratification.
- Recognition of these markers can guide management decisions for cirrhosis patients.
Related Concept Videos
Cirrhosis I: Introduction
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
